GRHL3 has an enhanced expression in CRC; also, high expression of GRHL3 was notably correlated with tumor size, TNM staging, invasion degree, and lymph node metastasis, which suggested that high expression of GRHL3 might tend to correlate with the severity of CRC malignancy potentially. Here, GRHL3 is linked to metastatic malignant neoplasm in the lymph nodes.